{
    "2021-01-29": [
        [
            {
                "time": "2021-02-25",
                "original_text": "J&J Slides On Less Effective Covid Vaccine; Moderna, BioNTech Pop",
                "features": {
                    "keywords": [
                        "J&J",
                        "Covid Vaccine",
                        "Less Effective",
                        "Moderna",
                        "BioNTech"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-28",
                "original_text": "Novavax Catapults To 6-Year High After Covid Vaccine Proves Highly Effective",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Covid Vaccine",
                        "Highly Effective",
                        "6-Year High"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "US STOCKS-Wall St drops after J&J vaccine data, GameStop effect weighs",
                "features": {
                    "keywords": [
                        "US Stocks",
                        "Wall St",
                        "J&J",
                        "vaccine data",
                        "GameStop"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "stocks",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-15",
                "original_text": "Now More Than Ever Why Pfizer Stock Is a Buy",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-29",
                "original_text": "Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Phase 3",
                        "Win",
                        "NVAX Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-23",
                "original_text": "Novavax Stock Soars as Its Covid-19 Vaccine Outperforms J&J’s",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Stock",
                        "Covid-19 Vaccine",
                        "Outperforms",
                        "J&J"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-22",
                "original_text": "European Cities Forced to Halt Vaccinations as Supply Issues Reach Crisis Point",
                "features": {
                    "keywords": [
                        "European Cities",
                        "Vaccinations",
                        "Supply Issues",
                        "Crisis Point"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "Pfizer's (PFE) Key Brands Likely to Drive Its Q4 Earnings",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Key Brands",
                        "Q4 Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "JNJ",
                        "NVS",
                        "Q4 Earnings",
                        "MRK",
                        "LLY",
                        "Coronavirus Updates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "Johnson & Johnson says one-dose vaccine is 72% effective in U.S.",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "one-dose vaccine",
                        "72%",
                        "effective",
                        "U.S."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}